Overview
Dihexa is a cognitive-focused compound. Angiotensin IV receptor agonist.
With a half-life of ~2 hours, Dihexa requires daily administration in most observed protocols. Taken orally, it has a bioavailability of approximately 50% via its primary route.
Half-life approximately 2 hours. Oral bioavailability approximately 50%. Very limited human pharmacokinetic data. One-compartment model.
Mechanism of Action
Dihexa's pharmacological activity involves the following key pathways:
Neurotrophin Modulation
Dihexa interacts with central nervous system pathways involved in neuroplasticity and cognitive function.
CNS Penetration
Dihexa reaches the central nervous system via intranasal administration, bypassing the blood-brain barrier.
Dosing Protocols
The following protocols represent commonly observed dosing patterns. These are observational summaries, not recommendations.
Dose
10 mg
Route
Oral
Frequency
2-3 times daily
Duration
4-12 weeks
Dose
20 mg
Route
Oral
Frequency
2-3 times daily
Duration
4-12 weeks
Reconstitution Steps
Dihexa is supplied as a lyophilized (freeze-dried) powder and requires reconstitution before use. Common vial sizes: 10 mg, 20 mg.
-
1
Gather Supplies
You will need your Dihexa lyophilized vial (typically 10 mg or 20 mg), bacteriostatic water for injection, an insulin syringe (100-unit), and alcohol swabs. Wash hands thoroughly before handling.
-
2
Swab and Prepare
Wipe the rubber septum of both the Dihexa vial and the bacteriostatic water vial with a fresh alcohol swab. Allow to air-dry for 10–15 seconds before proceeding.
-
3
Draw Bacteriostatic Water
Draw 2 mL of bacteriostatic water into a syringe for a 10 mg vial (yielding 5 mg/mL), or 2 mL for a 20 mg vial (yielding 10 mg/mL). Adjust volume based on your target concentration.
-
4
Add Water to Vial
Insert the needle at an angle so the stream of water flows down the inside glass wall of the vial rather than directly onto the powder. This minimises foaming and preserves peptide integrity.
-
5
Gently Swirl to Dissolve
Gently roll the vial between your palms until the powder is fully dissolved. Do not shake vigorously. The solution should appear clear. If cloudiness persists, allow to stand for a few minutes and swirl again.
-
6
Label and Store
Label the vial with the date reconstituted and concentration. Store reconstituted Dihexa refrigerated at 2–8°C. Use within 4 weeks of reconstitution.
Quick Reconstitution Math
10 mg vial + 2 mL bac water = 5 mg/mL (5,000 mcg/mL). For a 10 mg oral dose, draw 20 units on a 100-unit insulin syringe. For a 5 mg SubQ dose, draw 10 units. Use the Milligram reconstitution calculator for custom vial sizes.
Lyophilized vials stable at 2–8°C for 2+ years. Reconstituted solution stable refrigerated at 2–8°C for up to 4 weeks. Do not freeze the reconstituted solution.
Frequently Asked Questions
What is Dihexa and how does it work?
Dihexa is a synthetic oligopeptide derived from angiotensin IV that binds with high affinity to hepatocyte growth factor (HGF) and potentiates its activity at the c-Met receptor. Rather than simply mimicking a neurotransmitter, Dihexa facilitates HGF dimerization and amplifies a key neurotrophic signaling axis that promotes synaptogenesis and hippocampal neuronal spinogenesis. It is considered one of the more potent nootropic peptides investigated in preclinical research, with effects observed at doses many orders of magnitude lower than those typically required by conventional cognitive compounds.
What is the half-life of Dihexa and how long does it stay active?
Pharmacokinetic studies in animal models have reported an exceptionally long half-life for Dihexa – approximately 12–13 days following intravenous administration. This prolonged duration means active compound may persist in the system well beyond a single dose. Because of this, many community protocols use short-cycle or intermittent dosing approaches (e.g., 5 days on / 2 days off) rather than continuous daily use.
How long does Dihexa take to show cognitive effects?
Preclinical research in animal models demonstrated significant improvements in spatial learning and memory within the observation periods used, though human timeline data is limited to anecdotal reports. Community observations most commonly describe subjective effects on focus, verbal fluency, and memory recall appearing within 1–2 weeks of consistent use. Given the compound's long half-life, accumulation over the first several doses is expected before steady-state tissue levels are reached.
What are the commonly reported effects of Dihexa?
Community reports most frequently describe improvements in verbal fluency, working memory, and the ability to form associations and recall information. Enhanced mental clarity and a heightened sense of cognitive sharpness are also commonly noted. These observations are anecdotal and primarily derive from self-experimentation reports – no published human clinical trials have been completed for cognitive enhancement applications.
How is Dihexa administered – oral or subcutaneous?
Dihexa has been investigated via multiple routes. Oral administration is reported to be effective due to its modified structure giving it improved gastrointestinal stability relative to native angiotensin IV, though some degradation during first-pass metabolism is expected. Subcutaneous injection is also commonly reported in community protocols and is considered to offer more reliable systemic absorption. Common community doses range from 10–20 mg/day orally, with subcutaneous doses reported at roughly half the oral amount.
Does Dihexa need to be cycled and is it safe for long-term use?
No human safety trials have been completed for Dihexa. A concern noted in research literature is that the HGF/c-Met pathway that supports synaptogenesis is also implicated in cell proliferation, and the long-term effects of sustained pathway activation have not been studied in humans. For this reason, community protocols almost universally describe cycling Dihexa with defined off periods. Common observed cycle patterns are 4–8 weeks on followed by an equal or longer break period.